Task: Answer the multiple choice question.
Question: Which compound exhibits a -4.331% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CCCNC(=O)Cn1c(=O)n(C)c2ccccc21
b Cc1ccccc1OCC(=O)Nc1ccc(N2CCN(C(=O)C(C)C)CC2)c(Cl)c1
c CC1CCN(C(=O)CSc2ccc(-c3cccc([N+](=O)[O-])c3)nn2)CC1
d CSc1nc(C)cc(SC(C(C)=O)C(=O)Nc2ccccc2)n1
e CCCCN(C)C(=O)c1nc2ccccn2c1CN1CCN(c2cnccn2)CC1
Answer: a. CCCNC(=O)Cn1c(=O)n(C)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)Cn1c(=O)n(C)c2ccccc21
CCCNC(=O)Cn1c(=O)n(C)c2ccccc21
2-(3-methyl-2-oxobenzimidazol-1-yl)-N-propylacetamide